Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 5:20 PM
Ignite Modification Date:
2025-12-26 @ 5:20 PM
NCT ID:
NCT02673606
Eligibility Criteria:
Inclusion Criteria:
* Right-handed (Edinburgh Inventory - Oldfield 1971).
* SCID diagnosis consistent with none, current or past history of Axis I psychiatric disorders.
* To be matched for age, gender, and years of education, as well as self-identified race/ethnicity.
* For naturally cycling female subjects, stage of menstrual cycle will be ascertained by history, and by serological measures.
* For women on oral contraceptives, we will identify those using 20mcg ethinyl, 2nd or 3rd generation, monophasic
Exclusion Criteria:
* Psychiatric, neurologic or medical condition that would interfere with study procedures or confound results, ascertained by history.
* History of seizure or significant head trauma (i.e., extended loss of consciousness, neurological sequelae, or known structural brain lesion).
* History of Axis I psychiatric diagnosis; e.g., history of substance use disorder, psychotic disorder, bipolar disorder, tic disorder, or eating disorder.
* Use of psychotropic medication within 4 weeks prior to study (within 6 weeks for fluoxetine, or other long-lived compounds; within one year for neuroleptics).
* Pregnancy (to be ruled out by urine ß-HCG).
* Metallic implants or devices contraindicating magnetic resonance imaging.
* Use of oral contraceptives or non-oral contraceptives containing estrogen and progesterone within 3 months
* History of breast cancer.
* Allergy to peanut oil.
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT02673606
Study Brief:
Protocol Section:
NCT02673606